ClinicalTrials.Veeva

Menu

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Johns Hopkins University logo

Johns Hopkins University

Status

Enrolling

Conditions

Alzheimer Disease
Cognitive Impairment
Hearing Loss
Dementia

Treatments

Device: HEARS-NPS device
Behavioral: HEARS-NPS program

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06930560
5R01AG076525-02 (U.S. NIH Grant/Contract)
IRB00357244

Details and patient eligibility

About

This randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The community-delivered hearing care intervention utilizes tailored strategies to assess impact on communication, neuropsychiatric symptoms (NPS), and care partner distress.

Enrollment

300 estimated patients

Sex

All

Ages

60 to 100 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 60 - 100 years old
  • English-speaking
  • Diagnosis of probable Alzheimer's Disease or other related dementia according to the core clinical criteria outlined in the National Institute on Aging (NIA) and Alzheimer's Association Guidelines
  • Speech frequency pure tone average (0.5- 4 kHz) >25 db in the better-hearing ear; adult onset hearing loss
  • Availability of caregiver/study partner who is 18+ to participate in all study-related visits and who provides care supervision
  • Stable (for 2 weeks or longer) dosing of medication (e.g. antidepressants, antipsychotics) for neuropsychiatric symptoms

Exclusion criteria

  • Current self-reported use of hearing aid or amplification device
  • Medical contraindication to use hearing aids ( e.g. draining ears)
  • Inability to participate in the 1-month follow up

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

300 participants in 2 patient groups, including a placebo group

Immediate treatment
Experimental group
Treatment:
Behavioral: HEARS-NPS program
Device: HEARS-NPS device
Delayed treatment
Placebo Comparator group
Treatment:
Behavioral: HEARS-NPS program
Device: HEARS-NPS device

Trial contacts and locations

1

Loading...

Central trial contact

Esther Oh, MD, Ph.D.; Jami Trumbo, MSPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems